OR WAIT null SECS
August 20, 2025
Podcast
This episode focuses on latest advancements in CGM and diabetes management from the ADCES 2025 annual meeting.
August 18, 2025
This episode includes a breakdown of topline data from ATTAIN-1 and part 1 of the recap for ADCES 2025.
August 08, 2025
Article
Discover key advancements in endocrinology from July 2025, including FDA approvals and trial results.
July 23, 2025
Isaacs and Bellini walk through the newly released Preexisting Diabetes in Pregnancy guidelines, discussing each of the 10 recommendations.
July 21, 2025
Isaacs and Bellini discuss the highlights of the Endocrine Society’s annual meeting, from upcoming treatments to public education.
July 18, 2025
Isaacs, Bellini, and Levy discuss a currently recruiting trial investigating CGM metrics in pregnant individuals with type 1 diabetes.
July 17, 2025
Video
Shah discusses the stagnation of the T1D treatment landscape and the potential progress that GLP-1 RA research could present.
Philis-Tsimikas emphasized the impact of nonmedical factors on health and how clinicians can be cognizant of them in their patient management.
Shah discusses the results from the ADJUST-T1D trial comparing semaglutide to placebo, which saw a significant disparity in semaglutide’s favor.
July 15, 2025
Isaacs and Bellini cover 3 of the most pivotal trial results from the 85th annual American Diabetes Association conference in part 1 of this 2-part recap.
